Trial of Duvelisib in Combination With Either Romidepsin or Bortezomib in Relapsed/Refractory T-cell Lymphomas

Memorial Sloan Kettering Cancer Center, New York

Memorial Sloan Kettering Nassau (Limited protocol activities), Uniondale

Memorial Sloan Kettering Cancer Center @ Commack (Limitied protocol activities), Commack

University of Washington School of Medicine in St. Louis, St Louis

Washington University School of Medicine, St Louis

Stanford University Medical Center, Stanford

Dana Farber Cancer Institute, Boston

Memorial Sloan Kettering Cancer Center Basking Ridge (Limited protocol activities), Basking Ridge

Memorial Sloan Kettering Westchester (Limited protocol activities), Harrison

Memorial Sloan Kettering Monmouth (Limited protocol activities), Middletown

Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale